¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"one step growth experiment"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • one-tail test
    ´ÜÃø°ËÁ¤
  • phase encoding step
    À§»óºÎȣȭ´Ü°è
  • retromolar step osteotomy
    ¾î±Ý´ÏµÚ°è´Ü»ÀÀÚ¸§(¼ú), Èı¸Ä¡°è´Ü½ÄÀý°ñ(¼ú)
  • step
    1. °è´Ü 2. ´Ü°è 3. °ÉÀ½, º¸
  • step gips bandage
    º¸Ç༮°íºØ´ë
  • step ladder appearance
    »ç´Ù¸®¸ð¾ç
  • step osteotomy
    °è´Ü»ÀÀÚ¸§(¼ú), °è´ÜÀý°ñ(¼ú)
  • step rate insurance
    ´©Áøº¸Çè
  • step wedge
    °è´ÜÈí¼öü
  • step-down transformer
    °­¾Ðº¯¾Ð±â
  • short step gait
    ¼ÒÆøº¸Çà
  • apical growth
    ³¡¼ºÀå
  • appositional growth
    µ¡ºÙÀ̼ºÀå, ºÎ°¡¼ºÀå
  • asymmetric fetal growth restriction
    ºñ´ëĪžƼºÀåÁ¦ÇÑ
  • asynchronous growth
    ºñµ¿±âÁõ½Ä
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • peak growth velocity
    Ãִ뼺Àå¼Óµµ
  • growth zone
    ¼ºÀ屸¿ª
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • one probe method
    ´ÜÀÏŽ»öÀÚ¹æ½Ä, ´ÜÀÏÆ®·£½ºµà¼­¹æ½Ä
  • one stage sampling
    ÀϴܰèÇ¥º»ÃßÃâ¹ý
  • one-tail test
    ´ÜÃø°ËÁ¤
  • one-way valve
    ÀϹæÆÇ¸·
  • step ladder appearance
    °è´Ü¸ð¾ç
  • step gips bandage
    º¸Ç༮°íºØ´ë
  • step-down heating
    ´Ü°èº°°¨¿Â
  • step-up heating
    ´Ü°èº°°¡¿Â
  • incisal step
    Àý´Ü°è´Ü
  • step rate insurance
    ´©Áøº¸Çè
  • lingual step
    Çô°è´Ü
  • nasal step
    ÄÚÂʰè´Ü
  • retromolar step osteotomy
    ¾î±Ý´ÏµÚ°è´Ü»ÀÀÚ¸§¼ú, Èı¸Ä¡°è´Ü½ÄÀý°ñ¼ú
  • step osteotomy
    °è´Ü»ÀÀÚ¸§¼ú, °è´ÜÀý°ñ¼ú
  • phase encoding step
    À§»óºÎȣȭ´Ü°è
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Growth
    ¼ºÀå(à÷íþ)
  • Growth factor
    ¼ºÀåÀÎÀÚ(à÷íþì×í­)
  • Growth folic acid in
    ¼ºÀå(à÷íþ)¿°»ê(ç¤ß«)¿°
  • Growth hormone
    ¼ºÀå(à÷íþ)È£¸£¸ó
  • Growth hormone-inhibiting hormone
    ¼ºÀå(à÷íþ)È£¸£¸ó¾ïÁ¦(åäð¤)È£¸£¸ó
  • Growth hormone-releasing hormone
    ¼ºÀå(à÷íþ)È£¸£¸óºÐºñ(ÝÂÝô)È£¸£¸ó
  • Growth inducers
    ¼ºÀåÀ¯¹ßÀÎÀÚ(à÷íþë¯Û¡ì×í­)
  • Growth periods
    ¼ºÀå±â°£(à÷íþÑ¢Êà)
  • IGF-I(insulin-like growth factor-I)
    Àν¶¸° À¯»ç ¼ºÀåÀÎÀÚ-1
  • Insulin-like growth factors
    Àν¶¸°¾ç(å×)¼ºÀå(à÷íþ)È£¸£¸ó
  • Intrauterine growth retardation
    Àڱó» ¹ßÀ° Áö¿¬ (í­ÏàÒ® Û¡ëÀ òÀæÅ)
  • NGF=>nerve growth factor
    ½Å°æ¼ºÀåÀÎÀÚ
  • T cell growth factor (TCGF, IL-2)
    T¼¼Æ÷ Áõ½ÄÀÎÀÚ
  • T-cell growth factor
    T-¼¼Æ÷¼ºÀåÀÎÀÚ
  • TGF => transforming growth factor
    Àüȯ¼ºÀåÀÎÀÚ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • multi-step character
    ´Ù´Ü½Ä(ÒýÓ«ãÔ)¼º°Ý<--Ư¼º>
  • nasal step
    ºñÃø°è´Ü, ÄÚÂʰè´Ü
  • phase encoding step
    À§»ó ºÎÈ£ ´Ü°è
  • standard double two step test
    Ç¥ÁØÀÌÁßÀ̴ܰè½ÃÇè(ÊÙËöÌ¡ËöËÀË­ËàÌ´).
  • step
    °è´Ü ¿Íµ¿(èÀ÷Ó)ÀÇ .
  • step aeration
    °è´Ü(°è´Ü)¿¡¾î·¹À̼Ç
  • step down transformer
    °­¾Ðº¯¾Ð±â(˽äâܨäâÐï).
  • step gips bandage
    º¸Çà ¼®°í ºØ´ë(ÜÆú¼à´ÍÇÝÞÓá).
  • step ladder appearance
    °è´Ü ¸ð¾ç
  • step rate insurance
    ´©Áøº¸Çè(ËÈ̤ËÓÌ´).
  • step wedge
    °è´Ü Èí¼öü
  • step-down heating
    ´Ü°èº°°¨¿Â
  • step-up heating
    ´Ü°èº°°¡¿Â
  • three-step test
    »ï´Ü°è°Ë»ç
  • two point step test
    À̴ܰè½ÃÇè(ì£Ó«Í­ ãËúÐ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Meselson-Stahl experiment
    ¸Þ¼¿¼Õ-½ºÅ» ½ÇÇè(ãùúÐ)
  • Miller experiment
    ¹Ð·¯ ½ÇÇè(ãùúÐ)
  • playback experiment
    µÇµ¹¸² ½ÇÇè(ãùúÐ)
  • pulse-chase experiment
    ÆÞ½ºÃßÀû(õÚîæ) ½ÇÇè(ãùúÐ)
  • pulse-label experiment
    ÆÞ½º Ç¥Áö ½ÇÇè(øöò½ãùúÐ)
  • shotgun experiment
    ¼¦°Ç¹ý(Ûö)
  • anchorage independent growth
    °íÁ¤ºñÀÇÁ¸¼º¼ºÀå(ͳïÒÞªëîðíàõà÷íþ)
  • asynchronous growth
    ºñµ¿½Ã¼º ¼ºÀå (ÞªÔÒãÁàõà÷íþ)
  • balanced growth
    ±ÕÇü¼ºÀå(гû¬à÷íþ)
  • chain-growth polymer
    »ç½½½ÅÀå(ãßíþ)ÁßÇÕü(ñìùêô÷)
  • comb growth test
    °è°ü ¼ºÀå½ÃÇè(ͮήà÷íþãËúÐ)
  • confluent growth
    Àü¸é¼ºÀå(îïØüà÷íþ)
  • density-dependent growth
    "¹ÐµµÀÇÁ¸ ¼ºÀå(ÚËÓøëîðíà÷íþ), (ÔÒ) contact inhibition"
  • epidermal growth factor
    Ç¥ÇǼºÀåÀÎÀÚ (øúù«à÷íþì×í­)
  • epithelial growth factor
    »óÇǼºÀåÀÎÀÚ (ß¾ù«à÷íþì×í­)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
exp expansion; expectorant; experiment, experimental; expiration, expired; exponential function; exposur...
exper experiment, experimental
HCG, hCG Human Chorionic Gonadotropin; »ç¶÷À¶¸ð¼º¼º¼±ÀÚ±ØÈ£¸£¸ó
  1. Placental Glycoprotein Hormone
&nbs...
NG nasogastric; neoplastic growth; new growth; nitroglycerin; nodose ganglion; no growth; not given
TGF T-cell growth factor; transforming growth factor; tuboglomerular feedback; tumor growth factor
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
17,20 beta-P 17 alpha, 20 beta-dihydroxy-4-pregnen-3-one
2K1C 2 kidney one clip
20 alpha-OH-P 20 alpha-hydroxy-4-pregnan-3-one
CR1 Complement receptor type one
FEV1 Forced Expiratory Volume at one second
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • nasal step
    ºñÃø °è´Ü, ÄÚÂÊ °è´Ü
  • phase encoding step
    À§»ó ºÎÈ£ ´Ü°è
  • step down transformer
    ü°­ º¯¾Ð±â
  • step up transformer
    ü¼þ º¯¾Ð±â
  • step-back procedure
    Á¡ÁøÀû ÈĹæ À¯µµ¼ú
  • abnormal growth
    ºñÁ¤»ó ¼ºÀå
    ¼ºÀåÀÌ Á¤»óÀûÀÎ ¹üÀ§¸¦ ¹þ¾î³­ »óÅÂ. Á¤»óº¸´Ù »¡¸® ÀÚ¶ö ¼öµµ ÀÖ°í ´Ê°Ô ÀÚ¶ö ¼öµµ ÀÖ´Ù.
  • accessory growth substance
    ¹ßÀ° º¸Á¶ ¹°Áú
    ¹ßÀ°À» Çϴµ¥ º¸Á¶µÇ´Â ¹°Áú.
  • anchorage independent growth
    ºñºÎÂø Áõ½Ä, ºñºÎÂø ¹ßÀ°
  • appositional growth
    ºÎ°¡ ¼ºÀå
  • B cell growth factor
    B ¼¼Æ÷ ¼ºÀå ÀÎÀÚ, B ¼¼Æ÷ Áõ½Ä ÀÎÀÚ
    B ¼¼Æ÷°¡ ÇüÁú ¼¼Æ÷·Î ºÐÈ­ÇÏ´Â °úÁ¤Àº Å©°Ô 2´Ü°è·Î ³ª´©¾îÁø´Ù. Ç׿ø ÀÚ±ØÀ» ¹ÞÀº B ¼¼Æ÷´Â ¿ì¼± Áõ½ÄÇϰí, ±× ÈÄ¿¡ Ç×ü¸¦ »ý»êÇÏ¿© ºÐºñÇÏ´Â ÇüÁú ¼¼Æ÷·Î ºÐÈ­¸¦ ¿Ï¼öÇÑ´Ù. Ç׿ø ÀÚ±ØÀ» ¹ÞÀº B ¼¼Æ÷´Â ±× ÀÚÁ¦¸¸À¸·Î´Â Áõ½ÄÇÏÁö ¸øÇϰí T¼¼Æ÷ À¯·¡ÀÇ B ¼¼Æ÷ Áõ½Ä ÀÎÀÚ³ª Ž½Ä ¼¼Æ÷ À¯·¡ ÀÎÀÚ IL-1ÀÇ ÀÚ±ØÀÌ Ãß°¡µÇ¾î Áõ½ÄÀ» ½ÃÀÛÇÑ´Ù. B ¼¼Æ÷ Áõ½Ä ÀÎÀÚ´Â Á¤»óÀÇ T¼¼Æ÷¸¦
  • bone growth
    °ñ ¼ºÀå
    »ÀÀÇ Å©±â°¡ Áõ°¡ÇÏ´Â °ÍÀ¸·Î bone maturation
  • catch-up growth
    µû¶óÀâ±â ¼ºÀå
  • centrifugal growth
    ¿ø½É¼º ¼ºÀå
  • controlling factors in facial growth
    ¾È¸é ¼ºÀåÀÇ Á¶Àý ¿äÀÎ
  • deep invasive growth
    ½ÉºÎ ħÀÔ¼º ¼ºÀå
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
control experiment An experiment used to check another, to verify the result, or to demonstrate what would have occurred had the factor under study been omitted.
See: control, control animal.
(05 Mar 2000)
Scheiner's experiment A demonstration of accommodation; through two minute holes in a card, separated from each other by less than the diameter of the pupil, one looks at a pin; at a short distance from the eye the pin appears double; as it is moved from the eye a point is found where it appears single, and beyond which it remains single for the emmetropic eye, but for the myopic eye it soon again becomes double.
(05 Mar 2000)
hershey-chase experiment <molecular biology> A landmark experiment done in 1952 which showed that DNA is the hereditary material.
The experiment, done by Martha Hershey and Alfred Chase, involved allowing a bacteriophage which contained DNA labelled with 32P (an isotope of phosphorus) and a protein labelled with 35S (an isotope of sulphur) to attach to some bacteria.
When the bacteriophages were later removed, they found that it was the 32P (and thus the DNA) that had entered the bacterial cells rather than the 35S (indicating the protein).
(09 Oct 1997)
pulse-chase experiment An experiment in which an enzyme, a metabolic pathway, a culture of cells, etc., interacts with a brief addition (pulse) of a labelled compound followed by its removal and replacement (chase) by an excess of unlabelled compound.
(05 Mar 2000)
Stensen's experiment Compression of the abdominal aorta of an animal promptly causes paralysis of the posterior portions of the body since the blood supply to the lumbar cord is almost entirely shut off.
(05 Mar 2000)
Nussbaum's experiment Exclusion of the glomeruli of the kidney from the circulation by ligation of the renal artery in animals, such as the frog, that have a renal portal system to maintain circulation to the tubules.
(05 Mar 2000)
delayed reaction experiment A method of measuring memory: a stimulus is presented and removed before the organism is permitted to respond to it; the interval during which the stimulus is absent, providing the organism responds correctly, is an indication of the length of memory.
(05 Mar 2000)
double-blind experiment <statistics> An experiment conducted with neither experimenter nor subjects knowing which experiment is the control; prevents bias in recording results.
See: double-masked experiment.
(05 Mar 2000)
double-masked experiment A double-blind study conducted so neither the subject nor the observer know the identity of the control or variable.
(05 Mar 2000)
tokamak physics experiment <radiobiology> Smaller successor to TFTR at Princeton. Engineering design underway, construction scheduled to begin in FY 1995.
(09 Oct 1997)
experiment Noun: A procedure done in a controlled environment for the purpose of gathering observations, data, or facts, demonstrating known facts or theories, or testing hypotheses or theories. Verb: To carry out such a procedure.
(09 Oct 1997)
at one 1. In concord or friendship; in agreement (with each other); as, to be, bring, make, or set, at one, i. E, to be or bring in or to a state of agreement or reconciliation. "If gentil men, or othere of hir contree Were wrothe, she wolde bringen hem atoon." (Chaucer)
2. Of the same opinion; agreed; as, on these points we are at one.
3. Together. "He and Aufidius can no more atone Than violentest contrariety." (Shak)
2. To stand as an equivalent; to make reparation, compensation, or amends, for an offense or a crime. "The murderer fell, and blood atoned for blood." (Pope) "The ministry not atoning for their former conduct by any wise or popular measure." (Junius)
Origin: OE. At on, atone, atoon, attone.
Source: Websters Dictionary
(01 Mar 1998)
benzalcoumaran-3-one 1. 2-benzylidene-3(2H)-benzofuranone;the parent compound of a series of plant pigments; they are substituted coumaranones, and may be formed from chalcones. They are often found as glycosides.
2. A class of compounds based on aurone.
Synonym: benzalcoumaran-3-one.
(05 Mar 2000)
bufenolides (one double bond) (05 Mar 2000)
gel diffusion precipitin tests in one dimension Precipitin test's in which antigen solution and antibody incorporated in agar are layered in tubes, permitting effective diffusion in the vertical dimension; the antibody-containing agar may be overlaid directly with antigen solution (single (gel) diffusion in one dimension).
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • negative growth
    (°æÁ¦ÀÇ)¸¶À̳ʽº ¼ºÀå
  • nerve growth factor
    (»ý¸®)½Å°æ ¼ºÀåÀÎÀÚ(Áö°¢(±³°¨)½Å°æ¼¼Æ÷ÀÇ ¼ºÀåÀ» ÀÚ±ØÇÏ´Â ´Ü¹éÁú)
  • positive growth
    Ç÷¯½º ¼ºÀå
  • in step
    º¸Á¶¸¦ ¸ÂÃß¾î
  • step
    °È´Ù,º¸Çà,¹ß¼Ò¸®,µðµõÆÇ,óġ
  • step aside
    ¿·À¸·Î ºñÄѼ­´Ù
  • step in
    µé¾î°¡´Ù,µé·¯´Ù
  • dance step
    ´í½ºÀÇ ½ºÅÜ
  • false step
    °öµå·¯Áü;½ÇÃ¥
  • fire step
    ¹ßÆÇ;µðµõÆÇ
  • firing step
    =FIRE STEP
  • half step
    ¹ÝÀ½(semitone);¹Ýº¸
  • half step
    ¹ÝÀ½;¹Ý°ÉÀ½
  • side step
    ¿·À¸·Î ºñ۱â;ȸÇÇ
  • step
    °ÉÀ½;ÇѰÉÀ½;ÀϺ¸(ÀÇ °Å¸®);ªÀº °Å¸®;°ÉÀ½°ÉÀÌ;(´í½ºÀÇ)½ºÅÜ;Ãß´Â ¹ý;º¸Á¤;µðµõÆÇ;¹ß¼Ò¸®;¹ßÀÚ±¹;ÁøÀϺ¸;¼ö´Ü;Á¶Ä¡;°è±Þ;½Â±Þ;Á¶½ÉÇÏ´Ù;°È´Ù;°¡´Ù;ÀÏÁ¤ÇÑ °ÉÀ» °Å¸®·Î ³ª¾Æ°¡´Ù;(ÀÚµ¿Â÷ÀÇ ½ºÅ¸ÅÍ µûÀ§¸¦)¹â´Ù;±ÞÈ÷ °¡´Ù
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á